Researcher
Hans Van Vlierberghe
- Keywords:liver transplantation, hepatocellular carcinoma, liver diseases
- Disciplines:Cancer diagnosis, Cancer prevention, Cancer epidemiology, Cancer biology, Cancer therapy, Gastro-enterology and hepatology not elsewhere classified, Hepatology (incl. pancreas), Oncology not elsewhere classified, Gastro-enterology, Hepatology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2003 → 30 Sep 2018
Projects
1 - 10 of 19
- Development of cell-interactive and biodegradable AUP-based hydrogel materials for the fabrication of three-dimensional liver tissue engineering scaffoldsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Optimising the Human Detection of Cancer within Colorectal Polyps with a Simple Clinical AlgorithmFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Deubiquitinase UCHL1 targeting as part of new combinatorial treatments for hepatocellular carcinoma: a preclinical assessmentFrom1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- The role of Kupffer cells in the pathogenesis of hepatocellular carcinoma.From1 Nov 2021 → 31 Oct 2022Funding: Nonprofit institution or equivalents
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitisFrom1 Nov 2021 → TodayFunding: FWO fellowships
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis.From1 Oct 2021 → 31 Oct 2021Funding: BOF - doctoral mandates
- Dual targeting of CCr2 and CCR5 as thearpy for hepatocellular carcinoma: can we break immune tolerance?From1 Oct 2018 → 30 Sep 2022Funding: Nonprofit institution or equivalents
- Replacement of N-glycan analysis equipmentFrom1 Jun 2018 → 31 May 2020Funding: BOF - Other initiatives
- Startersbeurs Helena Degroote: The origin of tumor-associated macrophages and the therapeutic potential of dual targeting CCR2 and CCR5 as therapy for hepatocellular carcinomaFrom1 Oct 2017 → 30 Sep 2018Funding: Nonprofit institution or equivalents
Publications
11 - 20 of 103
- Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2020)
Authors: Sanne Van Campenhout, Laurentijn Tilleman, Sander Lefere, Aster Vandierendonck, Sarah Raevens, Xavier Verhelst, Anja Geerts, Filip Van Nieuwerburgh, Hans Van Vlierberghe, Lindsey Devisscher
- Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver(2020)
Authors: Anneleen Remmerie, Liesbet Martens, Tinne Thoné, Angela Castoldi, Ruth Seurinck, Benjamin Pavie, Joris Roels, Bavo Vanneste, Sofie De Prijck, Mathias Vanhockerhout, et al.
Pages: 641 - 657.e1–e14 - The angiopoietin/tie2 pathway in hepatocellular carcinoma(2020)
Authors: Bart Vanderborght, Sander Lefere, Hans Van Vlierberghe, Lindsey Devisscher
- Alanine aminotransferase during treatment predicts long-term survival in patients with autoimmune hepatitis type 1(2020)Volume: 72
Authors: Maaike Biewenga, Xavier Verhelst, Martine Baven-Pronk, Hein Putter, Aad P. Van den Berg, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe Van Steenkiste, Hans Van Vlierberghe, et al.
Pages: 736A - 737A - Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease(2020)
Authors: Sanne Van Campenhout, Agustina Ari Murti Budi Hastuti, Sander Lefere, Hans Van Vlierberghe, Frank Vanhaecke, Marta Costas Rodriguez, Lindsey Devisscher
- Common bile duct ligation as model for secondary biliary cirrhosis(2019)Series: Methods in Molecular Biology
Authors: Sanne Van Campenhout, Hans Van Vlierberghe, Lindsey Devisscher, Mathieu Vinken
Pages: 237 - 247 - Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide(2019)
Authors: Salvatore Piano, Virendra Singh, Paolo Caraceni, Rakhi Maiwall, Carlo Alessandria, Javier Fernandez, Elza Cotrim Soares, Dong Joon Kim, Sung Eun Kim, Monica Marino, et al.
Pages: 1368 - 1380 - Caucasian ethnicity, but not treatment cessation is associated with HBsAg loss following nucleos(t)ide analogue-induced HBeAg seroconversion(2019)
Authors: Stijn Van Hees, Heng Chi, Bettina Hansen, Stefan Bourgeois, Hans Van Vlierberghe, Thomas Serste, Sven Francque, David Wong, Dirk Sprengers, Christophe Moreno, et al.
- Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?(2019)
Authors: Pauline De Bruyn, Dirk Van Gestel, Piet Ost, Vibeke Kruse, Lieve Brochez, Hans Van Vlierberghe, Arnaud Devresse, Véronique del Marmol, Alain Le Moine, Sandrine Aspeslagh
Pages: 54 - 64 - Update on liver transplantation for cholangiocarcinoma : a review of the recent literature(2019)
Authors: Stéphanie Laurent, Xavier Verhelst, Anja Geerts, Karen Geboes, Marc De Man, Roberto Troisi, Xavier Rogiers, Frederik Berrevoet, Hans Van Vlierberghe
Pages: 417 - 420